Back to News
Market Impact: 0.3
Wednesday's ETF Movers: ARKG, EIS
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
The ARK Genomic Revolution ETF rose about 6.1% on Wednesday, outperforming other ETFs. Among its components, Pacific Biosciences of California gained about 22.5% and Prime Medicine rose about 19.3%; the article gives no reason for the gains.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
PACB0.40
PRME0.40
More News
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- Asian shares fall as Alphabet earnings miss drags Wall St futures lower
- Wall Street looks past Fed pause to tech earnings and AI rebound
- U.S. stock futures drop as Alphabet slides on soft earnings, Microsoft firms
- Lula's Brazil Election Win Deepens Latin America Stock Fund Collapse
- Fed chairman talks tough on inflation — plus, what's behind Micron's big rally